Optibrium Introduces StarDrop 5.4 to Target Novel, Safe and Efficacious Drugs
Optibrium Ltd.
11/06/2013Next generation software adds modules for knowledge-based prediction of toxicity and application of over 20,000 bioisosteric transformationsCAMBRIDGE, UK, 11 June, 2013 – Optibrium, a developer of software for drug discovery, today announced the release of version 5.4 of its StarDrop™ software platform. This new release offers enhanced features to guide the design of novel, safe and efficacious drugs by providing access to world-leading technologies for...